Chemotherapy for malignant gliomas.
作者： Paul L. Kornblith , Michael Walker
DOI: 10.3171/JNS.1988.68.1.0001
关键词:
摘要: ✓ There continues to be an extensive effort develop chemotherapeutic approaches the treatment of malignant gliomas brain. In past 5 years there have been literally hundreds trials new agents, combinations old and even routes delivery chemotherapy. this review, literature has studied individual reports analyzed evaluate impact findings on clinical management patient with glioma The major areas progress include addition drugs varying modes action, use in a synergistic fashion, development drug delivery. None advances brought about revolution care that is so eagerly sought, but clearly amount knowledge gained by these studies helps understanding how chemotherapy more effectively. Furthermore, remarkable degree interest involvement ...
sci-hub.se 参考文章(80)
Gehan Ea, Walker, Prognostic factors for patients with brain tumors. National Cancer Institute monograph. ,vol. 46, pp. 189- 195 ,(1977)
Brambilla C, Valagussa P, Solero Cl, Morello G, Vaghi A, Bonadonna G, Monfardini S, Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme. Cancer clinical trials. ,vol. 2, pp. 43- 48 ,(1979)
Jerzy Hildebrand, Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6-dioxodiethylester) in recurring supratentorial malignant brain gliomas - A phase II study European Journal of Cancer and Clinical Oncology. ,vol. 21, pp. 143- 146 ,(1985)
Mark L. Rosenblum, Massimo A. Gerosa, Charles B. Wilson, Geoffrey R. Barger, Bertran F. Pertuiset, Nicolas de Tribolet, Dolores V. Dougherty, Stem cell studies of human malignant brain tumors. Part 1: Development of the stem cell assay and its potential. Journal of Neurosurgery. ,vol. 58, pp. 170- 176 ,(1983) , 10.3171/JNS.1983.58.2.0170
MarkE. Ellis, RaymondB. Weiss, Mario Kuperminc, Nephrotoxicity of lomustine. A case report and literature review. Cancer Chemotherapy and Pharmacology. ,vol. 15, pp. 174- 175 ,(1985) , 10.1007/BF00257532
J. Ransohoff, C. B. Wilson, M. D. Walker, S. B. Green, D. P. Byar, J. T. Robertson, J. Mealey, W. R. Shapiro, R. G. Selker, T. A. Strike, W. H. Brooks, K. R. Smith, P. Paoletti, U. Batzdorf, G. L. Odom, D. A. Pistenmaa, W. E. Hunt, E. Alexander, Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer treatment reports. ,vol. 67, pp. 121- 132 ,(1983)
T J Kinsella, J B Mitchell, A Russo, M Aiken, G Morstyn, S M Hsu, J Rowland, E Glatstein, Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer. Journal of Clinical Oncology. ,vol. 2, pp. 1144- 1150 ,(1984) , 10.1200/JCO.1984.2.10.1144
C V Kufta, J M Collins, G A Curt, J A Kelley, P L Kornblith, B H Smith, R C Young, Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas Cancer Research. ,vol. 43, pp. 6102- 6105 ,(1983)
D G Thomas, J L Darling, E A Paul, T J Mott, J N Godlee, J S Tobias, L G Capra, C D Collins, C Mooney, T Bozek, G P Finn, S O Arigbabu, D E Bullard, N Shannon, R I Freshney, Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma. British Journal of Cancer. ,vol. 51, pp. 525- 532 ,(1985) , 10.1038/BJC.1985.75
David G. Payne, W. John Simpson, Colin Keen, Marjorie E. Platts, Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial Cancer. ,vol. 50, pp. 2301- 2306 ,(1982) , 10.1002/1097-0142(19821201)50:11<2301::AID-CNCR2820501114>3.0.CO;2-J